Ghayathri Jeyakumar

Hematology Oncology | Hematology | Oncology
615 W Avenue L
Lancaster, CA 93534

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy.

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy.

Journal: Journal for immunotherapy of cancer
Published: July 11, 2017

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study.

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study.

Journal: The Lancet. Oncology
Published: August 25, 2014

Discrepancy in diagnosis of primary myelofibrosis between referral and tertiary care centers.

Discrepancy in diagnosis of primary myelofibrosis between referral and tertiary care centers.

Journal: Leukemia research
Published: August 23, 2013
Showing 1-3 of 3

Last Updated: 09/26/2026